Mind Medicine (MindMed) Statistics
Total Valuation
MNMD has a market cap or net worth of $620.41 million. The enterprise value is $382.27 million.
Market Cap | 620.41M |
Enterprise Value | 382.27M |
Important Dates
The last earnings date was Wednesday, May 8, 2024, after market close.
Earnings Date | May 8, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
MNMD has 70.50 million shares outstanding. The number of shares has increased by 25.69% in one year.
Shares Outstanding | 70.50M |
Shares Change (YoY) | +25.69% |
Shares Change (QoQ) | +18.95% |
Owned by Insiders (%) | 2.67% |
Owned by Institutions (%) | 49.12% |
Float | 57.78M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 3.16 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.91, with a Debt / Equity ratio of 0.07.
Current Ratio | 3.91 |
Quick Ratio | n/a |
Debt / Equity | 0.07 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -287.75 |
Financial Efficiency
Return on equity (ROE) is -105.30% and return on invested capital (ROIC) is -45.28%.
Return on Equity (ROE) | -105.30% |
Return on Assets (ROA) | -73.30% |
Return on Capital (ROIC) | -45.28% |
Revenue Per Employee | n/a |
Profits Per Employee | -$2.20M |
Employee Count | 57 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +148.59% in the last 52 weeks. The beta is 2.48, so MNMD's price volatility has been higher than the market average.
Beta (1Y) | 2.48 |
52-Week Price Change | +148.59% |
50-Day Moving Average | 9.33 |
200-Day Moving Average | 5.35 |
Relative Strength Index (RSI) | 50.33 |
Average Volume (30 Days) | 2,394,892 |
Short Selling Information
The latest short interest is 6.13 million, so 8.70% of the outstanding shares have been sold short.
Short Interest | 6.13M |
Short Previous Month | 6.05M |
Short % of Shares Out | 8.70% |
Short % of Float | 10.62% |
Short Ratio (days to cover) | 5.27 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -95.21M |
Pretax Income | -125.32M |
Net Income | -125.32M |
EBITDA | -122.00M |
EBIT | -124.88M |
Earnings Per Share (EPS) | -$2.94 |
Balance Sheet
The company has $252.33 million in cash and $14.19 million in debt, giving a net cash position of $238.14 million or $3.38 per share.
Cash & Cash Equivalents | 252.33M |
Total Debt | 14.19M |
Net Cash | 238.14M |
Net Cash Per Share | $3.38 |
Equity / Book Value | 196.06M |
Book Value Per Share | 2.78 |
Working Capital | 190.20M |
Cash Flow
Operating Cash Flow | -67.63M |
Capital Expenditures | n/a |
Free Cash Flow | -67.63M |
FCF Per Share | -$1.41 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
MNMD does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -25.69% |
Shareholder Yield | -25.69% |
Earnings Yield | -20.20% |
FCF Yield | -10.90% |
Analyst Forecast
The average price target for MNMD is $23.50, which is 167.05% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $23.50 |
Price Target Difference | 167.05% |
Analyst Consensus | Strong Buy |
Analyst Count | 8 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on August 29, 2022. It was a reverse split with a ratio of 1:15.
Last Split Date | Aug 29, 2022 |
Split Type | Reverse |
Split Ratio | 1:15 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |